W A Bleyer. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antimetabolites, Antineoplastic/administration & dosageAntimetabolites, Antineoplastic/therapeutic useCytarabine/administration & dosageCytarabine/pharmacokineticsCytarabine/therapeutic useDelayed-Action PreparationsDrug CarriersHumansInjections, SpinalLiposomesMeningeal Neoplasms/drug therapyMethotrexate/pharmacokineticsMethotrexate/therapeutic use
Substances: See more » Antimetabolites, AntineoplasticDelayed-Action PreparationsDrug CarriersLiposomesCytarabineMethotrexate
Year: 1999 PMID: 10589743
Source DB: PubMed Journal: Clin Cancer Res ISSN: 1078-0432 Impact factor: 12.531